Patients who are admitted to the hospital with coronavirus disease 2019 (Covid-19) are at
high risk for thrombosis, particularly venous thromboembolism (VTE). In a meta-analysis of …

The pathogenic coronavirus has been wreaking havoc worldwide since January. Infection
with SARS-CoV-2 is problematic as no one has prior immunity, and no specific antiviral …

Acutely ill medical patients are at heightened risk for venous thromboembolism, a term that
combines deep vein thrombosis (DVT) and its more severe complication, pulmonary …

Coagulopathy in coronavirus infection has been shown to be associated with high mortality
with high D-dimers being a particularly important marker for the coagulopathy. 1 In the latest …

From the early days of the COVID-19 pandemic, a distinct coagulation disturbance of SARS-
CoV-2 infection has been recognized. This thrombo-inflammatory phenotype, characterized …

Background: Preliminary evidence indicates that prophylactic-dose thromboprophylaxis may
be inadequate to control the increased risk of venous thromboembolism (VTE) in patients …

Background Critically ill COVID-19 patients have a clear pattern of inflammation and
hypercoagulable state. The main aim of the study was to evaluate the outcome of severe …

Clinical, laboratory, and autopsy findings support an association between coronavirus
disease-2019 (COVID-19) and thromboembolic disease. Acute COVID-19 infection is …

The disease caused by coronavirus SARS-CoV-2, named COVID-19, has become a global
emergency. The virus spreads via respiratory droplets and is mainly responsible for …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …